Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Triton to sell Ovako to Nippon Steel & Sumitomo Metal Corporation, a global market leader in steel production

· Since Triton's acquisition, Ovako has strengthen its position as one of the leading European producer of engineering steel · Nippon Steel & Sumitomo Metal Corporation`s and Ovako's operations are complementary, have a great cultural fit and the combined business is expected to further enhance customer offerings · The parties have agreed not to disclose the terms of the transaction. The sale is subject to regulatory approval Stockholm (Sweden) / Tokyo (Japan), 15 March 2018 - Funds advised by Triton ("Triton") today announced the sale of Ovako AB ("Ovako"), a leading European

Report for the Fourth Quarter Ended December 31, 2017

This report includes unaudited consolidated financial information of Corral Petroleum Holdings AB (publ) and its consolidated subsidiaries, for the fourth quarter of 2017 and year ended December 2017 and for the comparative periods in 2016.Financial highlights – Fourth Quarter 2017 • Sales revenue for the fourth quarter of 2017 amounted to 19,156 MSEK compared to 17,826 MSEK in the fourth quarter of 2016.• EBITDA for the fourth quarter of 2017 amounted to 1,646 MSEK compared to 1,879 MSEK in the fourth quarter of 2016.• Adjusted EBITDA for the fourth quarter of 2017 amounted to 888

Teleste at Passenger Terminal Expo 2018: Keep passengers safe and improve operational efficiency at airports!

Turku, Finland – 15 March 2018 – Teleste Corporation will showcase its smart video surveillance and information management solution at Passenger Terminal Expo 2018 on 20-22 March in Stockholm, Sweden.  We invite you to visit us at stand 1301 to hear and talk about the possibilities the solution offers for airport operators! Guarantee the safety and security of passengers, personnel and operations each day Security systems nowadays play a crucial role at busy and crowded airports, as authorities and operators need to guarantee the safety and security of passengers, personnel and

Basware’s Enhanced Supplier Spend Dashboard Supports Strategic Procurement with Actionable Data

ESPOO, Finland, March 15, 2018, Basware, the leading provider of Source-to-Pay (S2P) solutions, has released enhancements to its Supplier Spend Dashboard, empowering customers with more actionable data to reduce costs and increase value through advanced analytics. Basware’s analytics for supplier spend deliver comprehensive spend visibility to help procurement professionals make better, faster and more confident buying decisions, and provides historical data and buying trends to support strategic supplier negotiations. The solution collects and analyzes procurement data to provide

Aspire Global considers the issuance of senior secured notes in the Nordic capital markets

Aspire Global plc (”Aspire Global” or the ”Company”) considers an issuance of senior secured notes in the Nordic capital markets. The Company has mandated Carnegie Investment Bank and Pareto Securities to arrange investor meetings commencing on 20 March, 2018. Aspire Global has in previous interim reports communicated the ambition to continue to actively look for interesting acquisition opportunities and to review the Company’s financing options in relation to this, including different sources of debt financing. In this context, Carnegie Investment Bank and Pareto Securities have been

Initiator Pharma A/S announces start of subscription period in the rights issue

Today, on March 15th, 2018, the subscription period in Initiator Pharma A/S’s (“Initiator Pharma”) rights issue of units, starts. The rights issue is also open to the public. The subscription period ends on March 29th, 2018. A fully subscribed initial issue provides Initiator Pharma with approximately SEK 19.1 million before issuing costs. In addition, the company can be provided with a further approximately SEK 12,7 million in case the initial issue is fully subscribed and all of the attached free-of-charge warrants of series TO 1 are exercised. In total, the offer thereby comprises a

In strategic move, Catena Media hires top talent to head finance vertical in London

As previously announced, Catena Media will expand its business in the financial services sector in 2018. Its content-led services will be offered to companies looking to acquire customers in competitive product verticals within the financial services sector. Nigel Frith, former Global GM at FXcompared.com, has been appointed to lead this new business vertical.Catena Media is now taking another step to deliver on its growth strategy. The new business line within financial services will be built through a combination of owned and operated brands and acquisitions, starting with the previously

Management change in Cloetta

Oskari Vidman has been appointed Chief Pick & Mix Officer. He will report to Henri de Sauvage-Nolting, CEO, and be part of Group Management.Oskari Vidman will assume his position as of 1 April, 2018. He succeeds Dani Evanoff, previously CEO of Candyking, who has decided to leave Cloetta to focus on his own investment company. Oskari Vidman is currently Sales Director Cloetta Finland. He has previously been working at British American Tobacco in various sales and marketing roles in the Nordic countries such as General Manager Norway and Finland. He was born in 1976 and holds a master

Cantargia presents new data at AACR on inhibition of metastasis by antibodies against IL1RAP.

Cantargia AB (“Cantargia”) today announces that data on the anti-metastatic properties of an antibody against interleukin 1 receptor accessory protein (IL1RAP) has been selected for poster presentation at the 2018 Annual Meeting of the American Association for Cancer Research, April 14-18 in Chicago.The poster “Antibody blockade of IL1RAP signaling reduces metastasis in a breast cancer model” by David Liberg, Per-Ola Önnervik, Matteo Riva, Liselotte Larsson, Göran Forsberg and Karin von Wachenfeldt will be presented at 08.00 local time on April 16, 2018 in the session “Therapeutic

Fiskars appoints Niklas Lindholm as Chief Human Resources Officer and member of the Fiskars Group Leadership Team

Fiskars CorporationStock Exchange ReleaseMarch 15, 2018 at 9:30 EET Fiskars appoints Niklas Lindholm as Chief Human Resources Officer and member of the Fiskars Group Leadership Team Fiskars has appointed Niklas Lindholm as Chief Human Resources Officer and member of the Fiskars Group Leadership Team (FGLT) from August 1, 2018. He will report to Fiskars President and CEO, Jaana Tuominen. As announced on January 11, 2018, Nina Ariluoma, who currently holds the position, will be leaving the company at the end of March.  "I warmly welcome Niklas to Fiskars. He has a strong track

Outokumpu - Announcement regarding change in holdings

Outokumpu OyjStock exchange releaseMarch 15, 2018 at 9.30 am EET Outokumpu – Announcement regarding change in holdings Outokumpu Oyj (business identity code: 0215254-2) has on March 14, 2018 received a notification based on Chapter 9, Section 5 of the Finnish Securities Market Act. JPMorgan Chase & Co.’s total holding in the shares and voting rights of Outokumpu has risen above 5% threshold and was 5.16% on March 13, 2018. Their earlier total holding in the Outokumpu shares and voting rights was below 5%. Total direct andindirect holdingsof JPMorgan Chase& Co. according

Orasolv AB will be transferred to AktieTorget´s observation list

Due to the public takeover bid of Orasolv AB that was announced today, AktieTorget has decided that the shares in Orasolv AB (OS) will be traded on AktieTorgets observation list from today March, 15th 2018. AktieTorget08-511 68 000e-post informationsoverakningen@aktietorget.se  About AktieTorget AktieTorget is a market place that wants to make it easier, safer and more visible for growth companies to become- and be listed. The company also offers investors the opportunity to become shareholders in growth companies in an easier and safer way. At AktieTorget there are more than

Update on Tawke PSC reserves and resources

15 March 2018 Genel Energy plc Update on Tawke PSC reserves and resources Genel Energy plc ('Genel') notes that DNO ASA, as operator of the Tawke PSC (Genel 25% working interest), has today issued an update on the Tawke licence reserves and resources. The Tawke licence contains the Tawke and Peshkabir fields. Gross oil reserves (MMboe) 1P 2P 3P31 December 2016 353 536 7252017 production (40.0) (40.0) (40.0)Technical revisions 35 17 19531 December 2017 348 513 880 2C resources totalled 91

Tobii and Qualcomm Collaborate to Bring Eye Tracking to Mobile VR/AR Headsets

Tobii announced a collaboration with Qualcomm Technologies, Inc. to make eye tracking technology available for mobile VR/AR head-mounted displays (HMDs) powered by the Qualcomm® Snapdragon™ 845 Mobile VR Platform. As a leading system on chip (SOC) provider, Qualcomm is positioned as a key technology partner for HMD device makers. For Tobii, today’s announcement is an important proof point for the significant demand, and substantial benefits, of incorporating eye tracking into VR/AR hardware. As a result of their collaboration, Tobii and Qualcomm are creating a full reference design and

NOTICE TO CONVENE THE ANNUAL GENERAL MEETING OF WULFF GROUP PLC

STOCK EXCHANGE RELEASE   15.3.2018 at 9.05 A.M. The Shareholders of Wulff Group Plc are invited to the Annual General Meeting to be held on Thursday April 5, 2018 at 12 P.M. at Vanha Ylioppilastalo (Old Student House), Music hall, Mannerheimintie 3, 00100 Helsinki, Finland. Reception of attendees will begin at 11.30 A.M. A) Matters to be handled by the Annual General Meeting 1. Opening the meeting 2. Calling the meeting to order 3. Electing of persons to confirm the minutes and to supervise the counting of votes 4. Recording the legality of the meeting 5. Recording the

Starbreeze announces the terms of its rights issue

THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, UNITED STATES, OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THE INFORMATION WOULD NOT COMPLY WITH OR REQUIRE REGISTRATION UNDER APPLICABLE LAWS AND REGULATIONS. STOCKHOLM (15 March, 2018) Starbreeze AB (publ) (“Starbreeze” or the “Company”) announced on 24 January 2018 that the Board of Directors had decided, subject to approval at the

Eastnine Nomination Committee proposes two new candidates and a new chairman

The Nomination Committee of Eastnine has resolved to nominate Johan Ljungberg and Peter Wågström for election as new Members of the Board of Directors at the company’s Annual General Meeting on 24 April 2018. In addition, current member Liselotte Hjorth is nominated as new Chairman of the Board.The proposal means that the Board will comprise five members, consisting of – alongside new candidates Johan Ljungberg and Peter Wågström – Peter Elam Håkansson, Liselotte Hjorth and Nadya Wells. Current board members Göran Bronner and Chairman Lars O Grönstedt have declined re-election. “With

BerGenBio: Promising data highlighting bemcentinib’s potential to improve efficacy of checkpoint inhibitors to be presented at AACR Annual Meeting

Bergen, Norway, 15 March 2017 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces that promising preclinical data with BerGenBio’s lead AXL inhibitor bemcentinib (formerly BGB324) will be featured at the 2018 American Association for Cancer Research (AACR) Annual Meeting on 14-18 April in Chicago, USA.The data highlight bemcentinib’s potential to reverse tumour immune suppression and enhance immune checkpoint inhibitor efficacy. These data continue to support the clinical

The H&M group’s sales development in the first quarter 2018

In the first quarter of 2018, i.e. during the period 1 December 2017 to 28 February 2018, the H&M group’s sales including VAT were unchanged in local currencies compared to the first quarter the previous year. Converted into SEK, sales amounted to SEK 53,554* m (54,369). Sales excluding VAT amounted to SEK 46,181* m (46,985). The total number of stores in the group amounted to 4,743 on 28 February 2018 compared to 4,393 stores at the same time the previous year. The three-month report to be published on 27 March 2018The three-month report, covering the period 1 December 2017 – 28

Hexagon acquires AGTEK, a leading software solutions provider to the civil construction industry

Hexagon AB, a leading global provider of information technology solutions, announced today the acquisition of AGTEK, a leading US based software company specialising in planning and productivity solutions for the heavy civil construction industry.With headquarters in Livermore, California, AGTEK is the pioneer of 3D takeoff (cost estimation) software for civil construction and the developer of the widely used Earthwork 4D, a complete takeoff, modelling, and production tracking solution for civil contractors. AGTEK’s products are aimed at streamlining the contractor’s workflow for

WULFF GROUP PLC'S ANNUAL REPORT, FINANCIAL STATEMENTS AND CORPORATE GOVERNANCE STATEMENT 2017 PUBLISHED

STOCK EXCHANGE RELEASE     15.3.2018 at 9.00 A.M. Wulff Group Plc’s Annual Report, Financial Statements and Corporate Governance Statement for 2017 have been published in English and Finnish. They are available as PDF files at the Group’s websitewww.wulff-group.com. The Annual Report can also be ordered from Wulff Group’s Investor Relations by: -       email: investors@wulff.fi-       telephone: +358 300 870 414-       regular mail: Manttaalitie 12, 01530 Vantaa, Finland. In Vantaa on March 15, 2018 WULFF GROUP PLCBOARD OF DIRECTORS Further information: CEO

Kungsleden has successfully issued its first green bond

Kungsleden AB (publ.) (“Kungsleden”) has successfully issued its first green bond of SEK 2,000 million with a tenor of four years under its MTN program.The bond consists of two tranches: one with a floating rate and one with a fixed rate. The tenor of both tranches is four years. The floating rate tranche amounts to SEK 1,250 million and has a floating rate coupon of STIBOR 3 months plus 205 bps, which corresponds to an initial coupon of circa 1.61 percent. The fixed rate tranche amounts to SEK 750 million and has a fixed rate equivalent to four year mid swap rate plus 205 bps, which

Itiviti and ULLINK complete merger to build a global technology force in the capital markets industry; Torben Munch appointed CEO

The Board of Directors of Itiviti AB announces that the transaction to merge the company with ULLINK was completed on March 14, 2018.With annual sales exceeding $200 million, 1,000 employees and local presence in major financial markets across Europe, Asia-Pacific and the Americas, the combination of Itiviti and ULLINK creates a full-service technology and infrastructure provider for global and regional financial institutions.  The intention to combine Itiviti and ULLINK was jointly communicated by the companies and owner Nordic Capital on November 28, 2017.  The Board has appointed

OxThera announces the randomization of the first patient into its phase III EPHEX study with Oxabact

Stockholm – 15 March 2018 – OxThera AB, a Stockholm-based privately-held biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria (PH), announces the randomization of the first patient into its phase III study, EPHEX, with Oxabact. Study OC5-DB-02 (EPHEX) is a randomized, placebo-controlled, 52-week study with the goal to investigate the efficacy and safety of Oxabact in patients with PH. The purpose of the study is to show that Oxabact can halt or delay the disease progression and preserve kidney function. “This is an important

There are no items matching the current filter
There are no more items matching the current filter
Back to top